Jubilant Biosys Limited
Jubilant Biosys Limited is a Public Non-govt company company incorporated in 1998 and based in Uttar Pradesh, India. Jubilant Biosys Limited operates in Pharmaceuticals & Chemicals (NIC 24110) with authorized capital of ₹258.00 Cr and paid-up capital of ₹252.14 Cr. For 2022-23, the company reported revenue of ₹545.15 Cr and profit after tax of ₹93.40 Cr. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Jubilant Biosys Limited is the legal entity of Jubilant Biosys.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Jubilant Biosys Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +27d | filed |
| MGT-7 | FY2024-25 | 21 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +28d | filed |
| MGT-7 | FY2023-24 | 21 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +32d | filed |
| MGT-7 | FY2022-23 | 23 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Jubilant Biosys Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 442252427 | Kotak Mahindra Bank Ltd(Bank) | ₹12.33 Cr | 27 Jan 2022 | Open |
| 953428560 | HDFC Bank Ltd(Bank) | ₹1.45 Cr | 04 Jul 2021 | Open |
| 614206014 | Axis Bank Ltd(Bank) | ₹7.79 Cr | 04 Jul 2023 | Open |
| 129885180 | HDFC Bank Ltd(Bank) | ₹7.11 Cr | 12 Mar 2020 | Satisfied |
| 961762065 | State Bank of India(Bank) | ₹63.67 L | 19 Sep 2022 | Open |
| 528682659 | Axis Bank Ltd(Bank) | ₹18.42 Cr | 27 Jan 2019 | Satisfied |
Charge IDs, lenders & amounts for Jubilant Biosys Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2022-23 | — | ||||
| 2021-22 | — | ||||
| 2017-18 | — | ||||
| 2015-16 | — | ||||
| 2014-15 | — |
Detailed Financials
4 FYs| Line item | 2022-23 | 2021-22 | 2017-18 | 2015-16 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2022-23 | +71.0% | +524.0% | — | |
| Profit after Tax2022-23 | -8.0% | — | — | |
| Net Worth2022-23 | +22.0% | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2014-15 | -51.09% | — | — | -33.23% | — | |||
| 2015-16 | -23.89% | +1.04% | — | -18.66% | — | |||
| 2017-18 | +0.00% | +43.27% | — | +0.00% | — | |||
| 2021-22 | +21.14% | +469.37% | +24.64% | +17.20% | 0.43 | |||
| 2022-23 | +17.13% | +13.56% | +18.51% | +11.43% | 0.62 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 1,93,44,664 | 58.30% |
| Institutional Investors | 1 | 21,36,906 | 6.44% |
| Public & Others | 8 | 1,16,99,820 | 35.26% |
Promoter, institutional & public holding for Jubilant Biosys Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
20 peersEvents & timeline
5External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.